An experimental pill called enlicitide slashed levels of low-density lipoprotein (LDL) cholesterol, commonly known as "bad" ...

According to DelveInsight's analysis, the primary sclerosing cholangitis market is anticipated to grow during the forecast period (2025--2034), driven by the launch of emerging therapies such as LB-P8 ...

Spruce Biosciences, Inc. , a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, announced ...

Scientists have discovered the cause of muscle pain and weakness experienced by some patients ...

Shift work and irregular eating patterns could affect liver function and disrupt its delicate circadian rhythm, University of Queensland researchers have found. Dr. Meltem Weger from UQ's Institute ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) has become the leading cause of liver disease worldwide, affecting one in three people.1,2 The inflammatory form of MASLD, namely ...

SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced ...

New research suggests the liver plays a previously unrecognized role in bone health, but only in males. A McGill ...

Proteins are the molecular machines of cells. They are produced in protein factories called ribosomes based on their ...

People are suddenly very concerned about the powerhouse of the cell.

Melissa B. Davis uses CRISPR screening to better understand how cancer affects underrepresented populations and find new potential therapeutic targets.